Study of Gemcitabine Plus Nab-Paclitaxel-Based Chemotherapy Regimen as First-Line Treatment in Metastatic Pancreatic Carcinoma

Background  The purpose of this study was to study the effectiveness of gemcitabine and nab-paclitaxel combination as first-line chemotherapy regimen for the treatment of metastatic pancreatic cancer. There is scarcity of data regarding efficacy and toxicity profile of this combination in Indian pop...

Descripción completa

Detalles Bibliográficos
Autores principales: Domadia, Kshitij, Goel, Varun, Koyyala, Venkata Pradeep Babu, Patnaik, Nivedita, Chaudhari, Krushna, Raina, Shubhra, Doval, D. C., Talwar, Vineet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273318/
https://www.ncbi.nlm.nih.gov/pubmed/35833047
http://dx.doi.org/10.1055/s-0041-1735956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273318/
https://www.ncbi.nlm.nih.gov/pubmed/35833047
http://dx.doi.org/10.1055/s-0041-1735956

Ejemplares similares